Literature DB >> 19076032

Silicon based materials for drug delivery devices and implants.

Delia L Bernik1.   

Abstract

This patent review focuses on silicon based materials for drug delivery systems and implant devices devoted to medical applications. The article describes some representative examples of the most depictive silicon based compounds associated with drug release formulations and tissue engineering biomaterials. Ranging from inorganic to organic and hybrid inorganic-organic silicon compounds, the paper referrers to patents describing inventions which make use of the best properties of silicon dioxide, silica aerogel and xerogel, silicon bioactive materials, silicones and ormosils, pointing out the usefulness of each kind of compound within the invention embodiment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19076032     DOI: 10.2174/187221007782360402

Source DB:  PubMed          Journal:  Recent Pat Nanotechnol        ISSN: 1872-2105            Impact factor:   1.952


  4 in total

1.  Cardioprotective effect of silicon-built restraint device (ASD), for left ventricular remodeling in rat heart failure model.

Authors:  Waqas Nawaz; Muhammad Naveed; Jing Zhang; Sobia Noreen; Muhammad Saeed; Kiganda Raymond Sembatya; Awais Ullah Ihsan; Imran Shair Mohammad; Gang Wang; Xiaohui Zhou
Journal:  J Mater Sci Mater Med       Date:  2022-05-10       Impact factor: 4.727

2.  Macroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation.

Authors:  Eileen Pedraza; Ann-Christina Brady; Christopher A Fraker; R Damaris Molano; Steven Sukert; Dora M Berman; Norma S Kenyon; Antonello Pileggi; Camillo Ricordi; Cherie L Stabler
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

Review 3.  Metalloid compounds as drugs.

Authors:  B S Sekhon
Journal:  Res Pharm Sci       Date:  2013-07

4.  A thermo-reversible silicone elastomer with remotely controlled self-healing.

Authors:  E Ogliani; L Yu; I Javakhishvili; A L Skov
Journal:  RSC Adv       Date:  2018-02-22       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.